Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ARNEIL G. C. 164 children with nephrosis. Lancet. 1961 Nov 18;2(7212):1103–1110. doi: 10.1016/s0140-6736(61)91026-1. [DOI] [PubMed] [Google Scholar]
- Abramowicz M., Barnett H. L., Edelmann C. M., Jr, Greifer I., Kobayashi O., Arneil G. C., Barron B. A., Gordillo-P G., Hallman N., Tiddens H. A. Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children. Lancet. 1970 May 9;1(7654):959–961. doi: 10.1016/s0140-6736(70)91093-7. [DOI] [PubMed] [Google Scholar]
- Aetiology of liver cancer. Br Med J. 1972 Jan 29;1(5795):261–262. [PMC free article] [PubMed] [Google Scholar]
- Allison D. P. Giant cells of Escherichia coli: a morphological study. J Bacteriol. 1971 Dec;108(3):1390–1401. doi: 10.1128/jb.108.3.1390-1401.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baliah T., Drummond K. N. The effect of anticoagulation on serum sickness nephritis in rabbits. Proc Soc Exp Biol Med. 1972 May;140(1):329–335. doi: 10.3181/00379727-140-36452. [DOI] [PubMed] [Google Scholar]
- Black D. A., Rose G., Brewer D. B. Controlled trial of prednisone in adult patients with the nephrotic syndrome. Br Med J. 1970 Aug 22;3(5720):421–426. doi: 10.1136/bmj.3.5720.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bokisch V. A., Müller-Eberhard H. J., Cochrane C. G. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J Exp Med. 1969 May 1;129(5):1109–1130. doi: 10.1084/jem.129.5.1109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Braunstein G. D., Lewis E. J., Galvanek E. G., Hamilton A., Bell W. R. The nephrotic syndrome associated with secondary syphilis. An immune deposit disease. Am J Med. 1970 May;48(5):643–648. doi: 10.1016/0002-9343(70)90016-1. [DOI] [PubMed] [Google Scholar]
- CUTLER S. J., EDERER F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958 Dec;8(6):699–712. doi: 10.1016/0021-9681(58)90126-7. [DOI] [PubMed] [Google Scholar]
- Cameron J. S., Boulton-Jones M., Robinson R., Ogg C. Treatment of lupus nephritis with cyclophosphamide. Lancet. 1970 Oct 24;2(7678):846–849. [PubMed] [Google Scholar]
- Cameron J. S. Glomerulonephritis. Br Med J. 1970 Oct 31;4(5730):285–289. doi: 10.1136/bmj.4.5730.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cameron J. S. Immunosuppressant agents in the treatment of glomerulonephritis. 2. Cytotoxic drugs. J R Coll Physicians Lond. 1971 Jul;5(4):301–322. [PMC free article] [PubMed] [Google Scholar]
- Cameron J. S., Kibukamusoke J. W. Plasma C 3 concentrations in malarial nephropathy. East Afr Med J. 1971 Sep;48(9):466–469. [PubMed] [Google Scholar]
- Cantrell E. G. Nephrotic syndrome cured by removal of gastric carcinoma. Br Med J. 1969 Jun 21;2(5659):739–740. doi: 10.1136/bmj.2.5659.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cheema A., Henson J. B., Gorham J. R. Aleutian disease of mink. Prevention of lesions by immunosuppression. Am J Pathol. 1972 Mar;66(3):543–556. [PMC free article] [PubMed] [Google Scholar]
- Churg J., Habib R., White R. H. Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet. 1970 Jun 20;760(1):1299–1302. doi: 10.1016/s0140-6736(70)91905-7. [DOI] [PubMed] [Google Scholar]
- Clarkson A. R., MacDonald M. K., Cash J. D., Robson J. S. Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis. Br Med J. 1972 Jul 29;3(5821):255–260. doi: 10.1136/bmj.3.5821.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clarkson A. R., MacDonald M. K., Petrie J. J., Cash J. D., Robson J. S. Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis. Br Med J. 1971 Aug;3(5772):447–451. doi: 10.1136/bmj.3.5772.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cochrane C. G. Immunologic tissue injury mediated by neutrophilic leukocytes. Adv Immunol. 1968;9:97–162. doi: 10.1016/s0065-2776(08)60442-3. [DOI] [PubMed] [Google Scholar]
- Cochrane C. G. Mediation of immunologic glomerular injury. Transplant Proc. 1969 Dec;1(4):949–958. [PubMed] [Google Scholar]
- DIXON F. J., FELDMAN J. D., VAZQUEZ J. J. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med. 1961 May 1;113:899–920. doi: 10.1084/jem.113.5.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DIXON F. J. THE ROLE OF ANTIGEN-ANTIBODY COMPLEXES IN DISEASE. Harvey Lect. 1963;58:21–52. [PubMed] [Google Scholar]
- Dixon F. J., McPhaul J. J., Lerner R. A. The contribution of kidney transplantation o the study of glomerulonephritis--the recurrence of glomerulonephritis in renal transplants. Transplant Proc. 1969 Mar;1(1):194–196. [PubMed] [Google Scholar]
- Dixon F. J. The pathogenesis of glomerulonephritis. Am J Med. 1968 Apr;44(4):493–498. doi: 10.1016/0002-9343(68)90050-8. [DOI] [PubMed] [Google Scholar]
- Feizi T., Gitlin N. Immune-complex disease of the kidney associated with chronic hepatitis and cryoglobulinaemia. Lancet. 1969 Oct 25;2(7626):873–876. doi: 10.1016/s0140-6736(69)92329-0. [DOI] [PubMed] [Google Scholar]
- Fong J. S., Good R. A. Suramin--a potent reversible and competitive inhibitor of complement systems. Clin Exp Immunol. 1972 Jan;10(1):127–138. [PMC free article] [PubMed] [Google Scholar]
- Gerber M. A., Paronetto F. IgE in glomeruli of patients with nephrotic syndrome. Lancet. 1971 May 29;1(7709):1097–1099. doi: 10.1016/s0140-6736(71)91838-1. [DOI] [PubMed] [Google Scholar]
- Germuth F. G., Jr, Senterfit L. B., Pollack A. D. Immune complex disease. I. Experimental acute and chronic glomerulonephritis. Johns Hopkins Med J. 1967 Apr;120(4):225–251. [PubMed] [Google Scholar]
- HARDWICKE J., SOOTHILL J. F., SQUIRE J. R., HOLTI G. Nephrotic syndrome with pollen hypersensitivity. Lancet. 1959 Mar 7;1(7071):500–502. doi: 10.1016/s0140-6736(59)91026-8. [DOI] [PubMed] [Google Scholar]
- HELYER B. J., HOWIE J. B. Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice. Nature. 1963 Jan 12;197:197–197. doi: 10.1038/197197a0. [DOI] [PubMed] [Google Scholar]
- Hellier M. D., Webster A. D., Eisinger A. J. Nephrotic syndrome: a complication of secondary syphilis. Br Med J. 1971 Nov 13;4(5784):404–405. doi: 10.1136/bmj.4.5784.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hirata A. A., Terasaki P. I. Cross-reactions between streptococcal M proteins and human transplantation antigens. Science. 1970 May 29;168(3935):1095–1096. doi: 10.1126/science.168.3935.1095. [DOI] [PubMed] [Google Scholar]
- Houba V., Allison A. C., Adeniyi A., Houba J. E. Immunoglobulin classes and complement in biopsies of Nigerian children with the nephrotic syndrome. Clin Exp Immunol. 1971 May;8(5):761–774. [PMC free article] [PubMed] [Google Scholar]
- KLEINERMAN J. Effects of heparin on experimental nephritis in rabbits. Lab Invest. 1954 Nov-Dec;3(6):495–508. [PubMed] [Google Scholar]
- Kincaid-Smith P., Laver M. C., Fairley K. F. Dipyridamole and anticoagulants in renal disease due to glomerular and vascular lesions. A new approach to therapy. Med J Aust. 1970 Jan 24;1(4):145–151. [PubMed] [Google Scholar]
- Kincaid-Smith P., Saker B. M., Fairley K. F. Anticoagulants in "irreversible" acute renal failure. Lancet. 1968 Dec 28;2(7583):1360–1363. doi: 10.1016/s0140-6736(68)92671-8. [DOI] [PubMed] [Google Scholar]
- Koffler D., Agnello V., Thoburn R., Kunkel H. G. Systemic lupus erythematosus: prototype of immune complex nephritis in man. J Exp Med. 1971 Sep 1;134(3 Pt 2):169s–179s. [PubMed] [Google Scholar]
- Lam C. N., McNeish A. S., Gibson A. A. Nephrotic syndrome associated with complement deficiency and Staphylococcus albus bacteraemia. Scott Med J. 1969 Mar;14(3):86–88. doi: 10.1177/003693306901400305. [DOI] [PubMed] [Google Scholar]
- Lerner R. A., Dixon F. J. The induction of acute glomerulonephritis in rabbits with soluble antigens isolated from normal homologous and autologous urine. J Immunol. 1968 Jun;100(6):1277–1287. [PubMed] [Google Scholar]
- Lerner R. A., Glassock R. J., Dixon F. J. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med. 1967 Dec 1;126(6):989–1004. doi: 10.1084/jem.126.6.989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lewis E. J., Carpenter C. B., Schur P. H. Serum complement component levels in human glomerulonephritis. Ann Intern Med. 1971 Oct;75(4):555–560. doi: 10.7326/0003-4819-75-4-555. [DOI] [PubMed] [Google Scholar]
- Lewis M. G., Loughridge L. W., Phillips T. M. Immunological studies in nephrotic syndrome associated with extrarenal malignant disease. Lancet. 1971 Jul 17;2(7716):134–135. doi: 10.1016/s0140-6736(71)92305-1. [DOI] [PubMed] [Google Scholar]
- MARKOWITZ A. S., LANGE C. F., Jr STREPTOCOCCAL RELATED GLOMERULONEPHRITIS. I. ISOLATION, IMMUNOCHEMISTRY AND COMPARATIVE CHEMISTRY OF SOLUBLE FRACTIONS FROM TYPE 12 NEPHRITOGENIC STREPTOCOCCI AND HUMAN GLOMERULI. J Immunol. 1964 Apr;92:565–575. [PubMed] [Google Scholar]
- Macanovic M., Evans D. J., Peters D. K. Alllergic response to glomerular basement membrane in patients with glomerulonephritis. Lancet. 1972 Jul 29;2(7770):207–210. doi: 10.1016/s0140-6736(72)91637-6. [DOI] [PubMed] [Google Scholar]
- Mallick N. P., Williams R. J., McFarlane H., Orr W. M., Taylor G., Williams G. Cell-mediated immunity in nephrotic syndrome. Lancet. 1972 Mar 4;1(7749):507–509. doi: 10.1016/s0140-6736(72)90174-2. [DOI] [PubMed] [Google Scholar]
- Markowitz A. S., Battifora H. A., Schwartz F., Aseron C. Immunological aspects of Goodpasture's syndrome. Clin Exp Immunol. 1968 Jul;3(6):585–591. [PMC free article] [PubMed] [Google Scholar]
- McGiven A. R. Blood coagulation and the effect of warfarin treatment on renal disease in NZB-NZW mice. Br J Exp Pathol. 1967 Oct;48(5):552–555. [PMC free article] [PubMed] [Google Scholar]
- Milgrom P., Klassen J., Fuji H. Immunologic injury of renal homografts. J Exp Med. 1971 Sep 1;134(3 Pt 2):193s–207s. [PubMed] [Google Scholar]
- Ngu J. L., Barratt T. M., Soothill J. F. Immunoconglutinin and complement changes in steroid sensitive relapsing nephrotic syndrome of children. Clin Exp Immunol. 1970 Jan;6(1):109–116. [PMC free article] [PubMed] [Google Scholar]
- Porter D. D., Larsen A. E., Porter H. G. The pathogenesis of Aleutian disease of mink. I. In vivo viral replication and the host antibody response to viral antigen. J Exp Med. 1969 Sep 1;130(3):575–593. doi: 10.1084/jem.130.3.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ROTH K. L. NOTES ON THE RELATIONSHIP BETWEEN THE THERAPEUTIC AND ANTICOMPLEMENTARY EFFECTS OF HEPARIN IN ACQUIRED HEMOLYTIC ANEMIA. Ann Allergy. 1965 Feb;23:83–92. [PubMed] [Google Scholar]
- Ratnoff O. D. Some relationships among hemostasis, fibrinolytic phenomena, immunity, and the inflammatory response. Adv Immunol. 1969;10:145–227. doi: 10.1016/s0065-2776(08)60417-4. [DOI] [PubMed] [Google Scholar]
- Richardson J. A., Rosenau W., Lee J. C., Hopper J., Jr Kidney transplantation for rapidly progressive glomerulonephritis. Lancet. 1970 Jul 25;2(7665):180–182. doi: 10.1016/s0140-6736(70)92536-5. [DOI] [PubMed] [Google Scholar]
- Rocklin R. E., Lewis E. J., David J. R. In vitro evidence for cellular hypersensitivity to glomerular-basement-membrane antigens in human glomerulonephritis. N Engl J Med. 1970 Sep 3;283(10):497–501. doi: 10.1056/NEJM197009032831001. [DOI] [PubMed] [Google Scholar]
- SCHWARTZ R., STACK J., DAMESHEK W. Effect of 6-mercaptopurine on antibody production. Proc Soc Exp Biol Med. 1958 Oct;99(1):164–167. doi: 10.3181/00379727-99-24281. [DOI] [PubMed] [Google Scholar]
- STEBLAY R. W. Glomerulonephritis induced in monkeys by injections of heterologous glomerular basement membrane and Freund's adjuvant. Nature. 1963 Mar 23;197:1173–1176. doi: 10.1038/1971173a0. [DOI] [PubMed] [Google Scholar]
- STEBLAY R. W. Glomerulonephritis induced in sheep by injections of heterologous glomerular basement membrane and Freund's complete adjuvant. J Exp Med. 1962 Aug 1;116:253–272. doi: 10.1084/jem.116.2.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steinberg A. D., Kaltreider H. B., Staples P. J., Goetzl E. J., Talal N., Decker J. L. Cyclophosphamide in lupus nephritis: a controlled trial. Ann Intern Med. 1971 Aug;75(2):165–171. doi: 10.7326/0003-4819-75-2-165. [DOI] [PubMed] [Google Scholar]
- Stickler G. B., Shin M. H., Burke E. C., Holley K. E., Miller R. H., Segar W. E. Diffuse glomerulonephritis associated with infected ventriculoatrial shunt. N Engl J Med. 1968 Nov 14;279(20):1077–1082. doi: 10.1056/NEJM196811142792003. [DOI] [PubMed] [Google Scholar]
- Sztejnbok M., Stewart A., Diamond H., Kaplan D. Azathioprine in the treatment of systemic lupus erythematosus. A controlled study. Arthritis Rheum. 1971 Sep-Oct;14(5):639–645. doi: 10.1002/art.1780140511. [DOI] [PubMed] [Google Scholar]
- Treser G., Semar M., McVicar M., Franklin M., Ty A., Sagel I., Lange K. Antigenic streptococcal components in acute glomerulonephritis. Science. 1969 Feb 14;163(3868):676–677. doi: 10.1126/science.163.3868.676. [DOI] [PubMed] [Google Scholar]
- Tu W. H., Shearn M. A., Lee J. C. Acute diffuse glomerulonephritis in acute staphylococcal endocarditis. Ann Intern Med. 1969 Aug;71(2):335–341. doi: 10.7326/0003-4819-71-2-335. [DOI] [PubMed] [Google Scholar]
- UNANUE E. R., DIXON F. J. EXPERIMENTAL GLOMERULONEPHRITIS. VI. THE AUTOLOGOUS PHASE OF NEPHROTOXIC SERUM NEPHRITIS. J Exp Med. 1965 May 1;121:715–725. doi: 10.1084/jem.121.5.715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Unanue E. R., Lee S., Dixon F. J., Feldman J. D. Experimental glomerulonephritis. VII. The absence of an autoimmune antikidney response in nephrotoxic serum nephritis. J Exp Med. 1965 Sep 1;122(3):565–578. doi: 10.1084/jem.122.3.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- VASSALLI P., MCCLUSKEY R. T. THE COAGULATION PROCESS AND GLOMERULAR DISEASE. Am J Med. 1965 Aug;39:179–183. doi: 10.1016/0002-9343(65)90040-9. [DOI] [PubMed] [Google Scholar]
- Vallota E. H., Forristal J., Spitzer R. E., Davis N. C., West C. D. Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum. J Exp Med. 1970 Jun 1;131(6):1306–1324. doi: 10.1084/jem.131.6.1306. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
- Vermylen J., Dotremont G., de Gaetano G., Donati M. B., Michielsen P. Indomethacin and urinary excretion of fibrinogen-like material in proliferative glomerulonephritis. Rev Eur Etud Clin Biol. 1970 Nov;15(9):979–984. [PubMed] [Google Scholar]
- WEST C. D., NORTHWAY J. D., DAVIS N. C. SERUM LEVELS OF BETA-1C GLOBULIN, A COMPLEMENT COMPONENT, IN THE NEPHRITIDES, LIPOID NEPHROSIS, AND OTHER CONDITIONS. J Clin Invest. 1964 Aug;43:1507–1517. doi: 10.1172/JCI105027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ward P. A., Kibukamusoke J. W. Evidence for soluble immune complexes in the pathogenesis of the glomerulonephritis of quartan malaria. Lancet. 1969 Feb 8;1(7589):283–285. doi: 10.1016/s0140-6736(69)91038-1. [DOI] [PubMed] [Google Scholar]
- Williams D. G., Kourilsky O., Morel-Maroger L., Peters D. K. C3 breakdown by serum from patients with acute post-streptococcal nephritis. Lancet. 1972 Aug 19;2(7773):360–361. doi: 10.1016/s0140-6736(72)91740-0. [DOI] [PubMed] [Google Scholar]
- Wittig H. J., Goldman A. S. Nephrotic syndrome associated with inhaled allergens. Lancet. 1970 Mar 14;1(7646):542–543. doi: 10.1016/s0140-6736(70)90770-1. [DOI] [PubMed] [Google Scholar]
- Zimmerman T. S., Arroyove C. M., Müller-Eberhard H. J. A blood coagulation abnormality in rabbits deficient in the sixth component of complement (C6) and its correction by purified C6. J Exp Med. 1971 Dec 1;134(6):1591–1600. doi: 10.1084/jem.134.6.1591. [DOI] [PMC free article] [PubMed] [Google Scholar]
